Biotechnology

Techseriesinsight > Blog > News > Biotechnology

February 27, 2026
Business Wire
Biotechnology, News

Zura Bio Closes $144 Million Public Offering to Advance Autoimmune Pipeline

Zura Bio Public Offering Raises $144 Million in Gross Proceeds The Zura Bio public offering has officially closed, raising approximately $144 million in gross proceeds to support the company’s...

February 27, 2026
Business Wire
Biotechnology, News

Cowellnex and Metagen Launch Joint Research on Gut Microbiota Testing

Gut microbiota testing is entering a new phase in Japan as Cowellnex Co., Ltd. and Metagen, Inc. announce a joint research initiative starting in February 2026. The partnership aims...

February 26, 2026
Business Wire
Biotechnology, News

Niagen Bioscience Sells ChromaDex Reference Standards Business to LGC in All-Cash Deal

Niagen Bioscience, Inc. has announced the sale of its ChromaDex Reference Standards business to LGC in an all-cash transaction completed on February 24, 2026. The move allows Niagen Bioscience...

February 26, 2026
Business Wire
Biotechnology, News

Compass Pathways Warrants Exercise Raises $200 Million

Compass Pathways plc (Nasdaq: CMPS) has announced the exercise of outstanding warrants, generating approximately $200 million in gross proceeds. The financing milestone strengthens the company’s balance sheet and supports...

February 26, 2026
PRNewswire
Biotechnology, News

CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075 Postbiotic

CJ BIO has published new clinical findings on BiomeNrich™ POST SZ075, reinforcing its position in the growing inner beauty market. The study appeared in the peer-reviewed journal Food Science...

February 26, 2026
PRNewswire
Biotechnology, News

genO-hFcγR Mouse Model Improves Antibody Therapy Prediction

Antibody therapies are transforming the treatment of cancer, inflammatory diseases, and infectious disorders. However, many promising drug candidates fail during late-stage clinical trials. A new study published in Science...

February 25, 2026
PRNewswire
Biotechnology, News

Scinai Immunotherapeutics Ltd. Secures Expanded IIA Support for Robotic Aseptic Fill & Finish Platform

Scinai IIA support has been expanded following an additional review by the Israel Innovation Authority (IIA). Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) announced that its robotic aseptic fill & finish...

February 25, 2026
Business Wire
Biotechnology, News

Leveragen, Inc. Secures Japan Patent for Singularity Platform

Leveragen Japan patent strengthens the company’s global intellectual property estate and reinforces its leadership in single-domain antibody discovery. Leveragen, Inc. announced the issuance of Japan Patent No. JP7799706 covering...

February 24, 2026
Business Wire
Biotechnology, News

Anti-PACAP Therapy: Slate Medicines Raises $130M to Advance Migraine Prevention

Anti-PACAP Therapy Company Slate Medicines Launches with $130M Anti-PACAP therapy developer Slate Medicines has launched with $130 million in Series A financing to advance a next-generation migraine prevention treatment....

February 24, 2026
PRNewswire
Biotechnology, News

Zentiva Urges EU to Pause Urban Waste Water Treatment Directive to Protect Medicine Availability

Zentiva Calls for EU Pause on Urban Waste Water Treatment Directive Zentiva has called for an EU-level “stop-the-clock” on the Urban Waste Water Treatment Directive (UWWTD), warning that its...